1. Home
  2. ABT vs T Comparison

ABT vs T Comparison

Compare ABT & T Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABT
  • T
  • Stock Information
  • Founded
  • ABT 1888
  • T 1983
  • Country
  • ABT United States
  • T United States
  • Employees
  • ABT N/A
  • T N/A
  • Industry
  • ABT Medical/Dental Instruments
  • T Telecommunications Equipment
  • Sector
  • ABT Health Care
  • T Telecommunications
  • Exchange
  • ABT Nasdaq
  • T Nasdaq
  • Market Cap
  • ABT 194.8B
  • T 159.3B
  • IPO Year
  • ABT N/A
  • T N/A
  • Fundamental
  • Price
  • ABT $113.45
  • T $22.29
  • Analyst Decision
  • ABT Buy
  • T Buy
  • Analyst Count
  • ABT 15
  • T 17
  • Target Price
  • ABT $129.80
  • T $25.35
  • AVG Volume (30 Days)
  • ABT 5.0M
  • T 33.5M
  • Earning Date
  • ABT 01-22-2025
  • T 01-27-2025
  • Dividend Yield
  • ABT 2.08%
  • T 4.98%
  • EPS Growth
  • ABT 12.04
  • T N/A
  • EPS
  • ABT 3.29
  • T 1.23
  • Revenue
  • ABT $41,217,000,000.00
  • T $122,060,000,000.00
  • Revenue This Year
  • ABT $5.70
  • T $1.73
  • Revenue Next Year
  • ABT $7.10
  • T $1.30
  • P/E Ratio
  • ABT $34.49
  • T $18.16
  • Revenue Growth
  • ABT 3.15
  • T 0.26
  • 52 Week Low
  • ABT $99.71
  • T $15.94
  • 52 Week High
  • ABT $121.64
  • T $24.03
  • Technical
  • Relative Strength Index (RSI)
  • ABT 48.55
  • T 46.65
  • Support Level
  • ABT $110.86
  • T $21.84
  • Resistance Level
  • ABT $113.81
  • T $23.17
  • Average True Range (ATR)
  • ABT 1.66
  • T 0.36
  • MACD
  • ABT 0.06
  • T -0.05
  • Stochastic Oscillator
  • ABT 50.88
  • T 50.56

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

About T AT&T Inc.

The wireless business contributes nearly 70% of AT&T's revenue. The firm is the third-largest US wireless carrier, connecting 72 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 15% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential fixed-line services, about 11% of revenue, primarily consist of broadband internet access, serving 14 million customers. AT&T also has a sizable presence in Mexico, with 23 million customers, but this business only accounts for 4% of revenue. The firm recently agreed to sell its 70% equity stake in satellite television provider DirecTV to its partner, private equity firm TPG.

Share on Social Networks: